lymphocytes
Cell therapyexperimental
A lymphocyte is a type of white blood cell (leukocyte) in the immune system of most vertebrates. Lymphocytes include T cells, B cells, and innate lymphoid cells, of which natural killer cells are an important subtype. They are the main type of cell found in lymph, which prompted the name "lymphocyte". Lymphocytes make up between 18% and 42% of circulating white blood cells. — Wikipedia
Clinical trial activity
11 trials · 13 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 1999 (NCT00001832)
Timeline
Indications
Studied for
- Burkitt Lymphoma · Phase 2
- Carcinoma, Hepatocellular · Phase 2
- Carcinoma, Renal Cell · Phase 2
- Hematologic Neoplasms · Phase 2
- HIV Infections · Phase 1
- Leukemia, Myeloid, Acute · Phase 2
- Lymphoma, Large B-Cell, Diffuse · Phase 2
- Lymphoma, Mantle-Cell · Phase 2
- Lymphoma, T-Cell · Phase 2
- Melanoma · Phase 2
- Neoplasm Metastasis · Phase 2
- Precursor Cell Lymphoblastic Leukemia-Lymphoma · Phase 2
Mechanism of action
- LymphocytesSupplementation
supplementation - lymphocytes
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLymphocyte ↗
Also known as
- activated lymphocytes
- lymphocyte
- lymphocyte
- lymphocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06861348 | Phase 2 | Mar 1, 2025 | Zhejiang University |
| NCT05213637 | Phase 2 | Apr 25, 2018 | People's Liberation Army of China, Zhejiang Yongtai |
| NCT02516371 | N/A | Aug 31, 2015 | Catholic University of Korea |
| NCT02199041 | Phase 2 | Jul 11, 2014 | St. Jude Children's Hospital |
| NCT01685606 | Phase 2 | Mar 1, 2013 | Brown University |
| NCT01350232 | N/A | Sep 1, 2009 | National Heart, Lung, and Blood Institute (NHLBI), Thomas Jefferson University |
| NCT00151645 | Phase 2 | Dec 1, 2003 | Government of France, University of Rennes |
| NCT00000756 | Phase 1 | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00000875 | N/A | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00000824 | N/A | Nov 2, 1999 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00001832 | Phase 2 | Aug 1, 1999 | National Cancer Institute (NCI), National Institutes of Health (NIH) |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (13)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 2 | 1999 |
| Brown University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Catholic University of Korea | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Government of France | Government | 1 | 0 | 1 | 2003 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 1999 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2009 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 1999 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2018 |
| St. Jude Children's Hospital | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Thomas Jefferson University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| University of Rennes | Academic/Hospital | 1 | 1 | 1 | 2003 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Zhejiang Yongtai | For profit | 1 | 0 | 1 | 2018 |
13 organizations
Page 1 / 1